• ERAD-Hijacking ERADECs Enable Targeted Degradation of TM Pro

  2026-07-09

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a small-molecule technology that selectively degrades transmembrane proteins by hijacking the ER-associated degradation pathway. This innovation overcomes key limitations in traditional proteolysis-targeting platforms and provides a foundation for targeted intervention in membrane protein-driven diseases.

• Ciclesonide: Unlocking Precision in Respiratory and ERAD Res

  2026-07-09

  Explore how ciclesonide’s prodrug activation and potent glucocorticoid receptor engagement are redefining translational respiratory research. This article connects advanced mechanistic insight, validated protocols, and the emergence of ERAD-hijacking strategies, offering researchers a roadmap to model both anti-inflammatory responses and targeted membrane protein degradation with greater fidelity. Learn how APExBIO’s ciclesonide enables reproducible, state-of-the-art experimentation in the evolving landscape of asthma, allergic rhinitis, and transmembrane protein research.

• Rosiglitazone (Brl-49653): PPARγ Rescue in Rare Lipodystroph

  2026-07-08

  Explore how Rosiglitazone, a synthetic thiazolidinedione PPARγ agonist, uniquely restores metabolic function in rare monogenic lipodystrophy. This article offers advanced insights beyond standard type II diabetes research.

• 5-Methyl-CTP: Enhancing mRNA Synthesis and Stability

  2026-07-08

  5-Methyl-CTP is a 5-methyl modified cytidine triphosphate that improves mRNA synthesis fidelity and enhances transcript stability for in vitro transcription workflows. Its methylated structure mimics natural mRNA modifications, leading to increased translation efficiency and resistance to degradation, which is crucial for mRNA therapeutics and personalized vaccine development.

• One-step TUNEL FITC Kit: Apoptosis Detection in IVDD Models

  2026-07-07

  Explore how the One-step TUNEL FITC Apoptosis Detection Kit enables sensitive DNA fragmentation analysis in intervertebral disc degeneration (IVDD) models. Gain new insights into assay selection, protocol optimization, and the translation of apoptosis detection to complex tissue environments.

• Comparative Antibacterial Efficacy of Cefoperazone and MK078

  2026-07-07

  This article reviews the landmark comparative analysis of N-formimidoyl thienamycin (MK0787) and several advanced β-lactam antibiotics—including cefoperazone sodium salt—against resistant clinical bacterial isolates. The findings clarify the nuanced spectrum of activity, β-lactamase stability, and bactericidal potential, shaping experimental design in antimicrobial research.

• Quizartinib (AC220): Precision FLT3 Inhibition for AML Resea

  2026-07-06

  Quizartinib (AC220) delivers nanomolar potency and unparalleled FLT3 selectivity, redefining workflows in acute myeloid leukemia (AML) and resistance studies. Discover how robust protocol design and recent mechanistic insights from drug resistance models can help you troubleshoot, optimize, and extend the impact of FLT3 inhibition in both AML and advanced CML research.

• Modeling Human SAN-Neural Maturation with PSC-Derived Assemb

  2026-07-06

  This study introduces a human in vitro tri-assembloid system integrating pluripotent stem cell-derived sinoatrial node and cardiac plexus organoids, enabling detailed investigation of neuron-to-pacemaker signaling and maturation. The model provides new insights into neuro-cardiac crosstalk, advancing research into human-specific pacemaker development and conduction disorders.

• Protoporphyrin IX: Photodynamic Compound in Heme and Cancer

  2026-07-05

  Protoporphyrin IX is a critical photodynamic compound and the final intermediate in heme biosynthesis. Its role spans iron chelation in heme formation, photodynamic cancer diagnosis, and the study of ferroptosis resistance. This article consolidates atomic facts, recent mechanistic evidence, and best practices for laboratory use.

• Indomethacin in Inflammation Research: Protocols & Innovatio

  2026-07-04

  Indomethacin’s dual role as a Cox-1 selective inhibitor and PPARγ agonist unlocks targeted control over inflammation and lipid signaling in cell and animal models. This guide details optimized workflows, troubleshooting, and practical insights for leveraging APExBIO’s Indomethacin in cutting-edge anti-inflammatory drug research.

• RIPA Lysis Buffer (Strong): Precision Protein Extraction Wor

  2026-07-03

  RIPA Lysis Buffer (Strong) empowers researchers to extract high-integrity proteins from challenging animal tissues and cultured cells, enabling advanced epigenetic and signaling studies. Learn how this robust buffer streamlines workflows for Western blotting, immunoprecipitation, and more, with troubleshooting tips and protocol enhancements built on real experimental insights.

• Sulforaphane Inhibits NLRP3 Inflammasome in Ulcerative Colit

  2026-07-03

  This study demonstrates that sulforaphane, a naturally occurring isothiocyanate, reduces oxidative stress and suppresses NLRP3 inflammasome activation in a dextran sodium sulfate-induced mouse model of ulcerative colitis. The findings provide mechanistic insight into sulforaphane’s anti-inflammatory effects and highlight its relevance as a research tool for investigating inflammasome-driven pathologies.

• Ciclesonide for Asthma Research: Protocols, Innovations & Tr

  2026-07-02

  Ciclesonide, a potent prodrug glucocorticoid, transforms respiratory and protein degradation research with targeted activation and robust anti-inflammatory efficacy. This article delivers actionable protocols, troubleshooting strategies, and cross-domain insights, leveraging both bench data and the latest ERAD-hijacking breakthroughs.

• CAFs Drive Chemoresistance via ANGPTL4-IQGAP1 in Prostate Ca

  2026-07-02

  This study reveals how cancer-associated fibroblasts (CAFs) in the prostate tumor microenvironment induce chemoresistance by modulating mitochondrial metabolism through the ANGPTL4-IQGAP1 axis. Targeting this pathway, the research provides mechanistic insights and highlights experimental strategies for dissecting complex cell-cell interactions in chemoresistant cancers.

• Direct Mouse Genotyping Kit: Precision in Disease Model Rese

  2026-07-01

  Explore how the Direct Mouse Genotyping Kit enables high-fidelity PCR amplification from mouse tissue, streamlining workflows for advanced biomedical research. This article uniquely connects rapid genotyping to the study of disease mechanisms in murine models, offering new insights beyond current content.

454 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page